医学
生物标志物
疾病
孟德尔随机化
肿瘤科
生物信息学
内科学
肾脏疾病
ALDH2
诊断生物标志物
白藜芦醇
基因表达谱
机器学习
临床试验
肾
糖尿病
计算生物学
精密医学
Lasso(编程语言)
微阵列
代谢组学
痛风
诊断准确性
病理
急性肾损伤
作者
Jingwei Lin,Yingying Zheng,Diman Mai,Fuxiang Fang,Zhuokun Wei,Mengyu Liu,Trung C. Pham,Ming Li,Jiawen Zhao
出处
期刊:Renal Failure
[Taylor & Francis]
日期:2025-10-29
卷期号:47 (1): 2577849-2577849
被引量:5
标识
DOI:10.1080/0886022x.2025.2577849
摘要
Diabetic kidney disease (DKD), the leading cause of end-stage kidney disease worldwide, demands deeper molecular characterization to improve clinical management. This study employed an integrated multi-omics approach to identify stage-specific biomarkers and molecular mechanisms distinguishing early- and late-stage DKD. Initial bulk RNA-seq analysis (thresholds: |logFC|>0.585, FDR < 0.05) revealed differentially expressed genes and enriched pathways, followed by two-sample Mendelian randomization (IVW p < 0.05) to pinpoint causal genes. Diagnostic modeling combined LASSO regression (10-fold cross-validation) with four machine learning algorithms (Random Forest, SVM, GLM, and XGBoost), validated in an independent cohort. Single-cell resolution analysis mapped candidate gene expression patterns, while molecular docking screened potential therapeutics. Through an integrated validation pipeline, FN1 (OR = 1.32) and ALDH2 (OR = 0.76) were established as core diagnostic biomarkers. FN1 (upregulated in mesangial cells) and ALDH2 (downregulated in proximal tubules) were validated as stage-specific biomarkers of DKD progression. FN1 expression negatively correlated with eGFR decline, while ALDH2 positively correlated. Resveratrol showed high-affinity docking to FN1 and ALDH2, suggesting dual-target therapeutic potential. These findings position FN1, ALDH2, and resveratrol as central references for DKD biomarker discovery, progression staging, and therapeutic development.
科研通智能强力驱动
Strongly Powered by AbleSci AI